Indicators

Markets:

News

Latest News about AWKNF

Recent news which mentions AWKNF

< Previous 1 2 3 Next >

World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them

August 30, 2022

There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market

August 19, 2022

Awakn's Second Licensing Partnership Agreement In A Week, This Time In Canada: Ketamine For Pain Comorbidities

August 18, 2022

Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder

August 16, 2022

Phase 3 Trial On Ketamine Therapy Gets Almost $2M From UK State Funding

July 20, 2022

Awakn Life Sciences Receives Funding From UK Government To Identify Most Efficient Go-To-Market Pathway For Proprietary Ketamine-Assisted Therapy

July 18, 2022

Awakn Life Sciences: Business And Corporate Update For Psychedelics Biotech

July 15, 2022

Michael Pollan's 'How To Change Your Mind' Now On Netflix, Here Are Reactions From Experts

July 14, 2022

UK To Fund Development Of Awakn's Ketamine-Assisted Therapy Program For Alcohol Use Disorder In US And UK

July 05, 2022

Michael Pollan's 'How To Change Your Mind' Coming Soon To Netflix: Documentary Based On Psychedelics Best Seller

June 17, 2022

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

June 02, 2022

Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company

May 24, 2022

Awakn Life Sciences Reports Completing World's First Ketamine Study For A Range Of Behavioral Addictions

May 24, 2022

Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research

May 19, 2022

Wake-Up Call: This Biotech Company Is Using Psychedelics To Treat Addiction

May 05, 2022

Core One Labs Begins Trading On OTCQB

April 06, 2022

Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!

April 06, 2022

Stifel Initiates Coverage On Awakn Life Sciences With A Speculative Buy, $8 Target Price Target

April 04, 2022

This Biotech Company Is Landing Ketamine-Assisted Therapy In England's Capital

March 31, 2022

Awakn Life Sciences Seeks To Treat Addictions: Gambling, Binge Eating And Compulsive Sexual Behavior

March 28, 2022

This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction

March 24, 2022

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today

February 08, 2022

Mind Medicine, Allied Among Top Psychedelic Movers Of Today

February 02, 2022

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today

January 27, 2022

Psychedelic Stock Gainers And Losers From January 24, 2022

January 24, 2022

Psychedelic Stock Gainers And Losers From January 21, 2022

January 21, 2022

Psychedelic Stock Gainers And Losers From January 20, 2022

January 20, 2022

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today

January 19, 2022

Psychedelic Stock Gainers And Losers From January 18, 2022

January 18, 2022

Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS

January 18, 2022

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.